Labetalol Hydrochloride 00409-0125-25

Package NDC

00409-0125-25

Manufacturer: Hospira, Inc.
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: August 7, 2023
Listing Expires: December 31, 2026
Application: ANDA075240

Need to source Labetalol Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Labetalol Hydrochloride	5 mg/mL

Drug Class

Adrenergic beta-Antagonists [MoA]beta-Adrenergic Blocker [EPC]

Selected Package

00409-0125-25Selected

25 VIAL, MULTI-DOSE in 1 TRAY (0409-0125-25) / 20 mL in 1 VIAL, MULTI-DOSE (0409-0125-01)